EATG » Cure

Cure

Top HIV cure research team refutes major recent results on how to identify HIV persistence

Collaborative effort sets the record straight on the use of CD32 as a biomarker to measure HIV reservoirs. PHILADELPHIA — (April 18, 2018) — An international team focused on HIV…

Has basic science in HIV research stalled?

Now that effective therapies for active HIV infection are broadly available, there should be renewed focus on basic science regarding HIV, said experts contacted by MedPage Today. Without it, they…

HIV i-Base: HTB, special CROI issue

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. This is the second issue of HTB to lead with reports from CROI 2018, the main annual HIV…

HIVACAR: EATG reports from the second general assembly of the consortium

On March 15-16 the European AIDS Treatment Group participated in the second general assembly meeting of the HIVACAR consortium in Digem (Belgium). The EATG in collaboration with the Complutense University…

HIV i-Base: HTB, first reports from CROI 2018

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. This edition of HTB includes the first reports from CROI 2018, with additional reports following in subsequent issues.…

Targeting HIV: Moving closer to a potential cure

Tri-specific antibody targets and neutralizes 99.5% of HIV-1 virus strains ROCKVILLE, Md., March 13, 2018: A team of researchers at IBBR, led by Dr. Yuxing Li, Associate Professor at the…

CROI 2018: Very early treatment in children limits the HIV reservoir

Very early HIV treatment in infants is feasible and safe and leads to a small reservoir of infected cells, two studies from Botswana and Thailand show. The findings offer hope…

Progress toward a better “shock and kill”?

amfAR-funded scientist Dr. Brad Jones of George Washington University in Washington, DC, has discovered an obstacle to the “shock and kill” strategy for curing HIV that may have implications for…

New way found to defeat HIV latency

SACRAMENTO, Calif., March 7, 2018 — HIV, the virus that causes AIDS, has a secret life. Though anti-retroviral therapy can reduce its numbers, the virus can hide and avoid both…

CROI 2018: No HIV evolution in plasma or lymph nodes on suppressive ART and no impact from further intensification

Two studies with implications for cure research were included in the CROI 2018 press conference on Sunday (March 4), with full presentations on Tuesday (March 6). Both support the idea…